FDA Drug Application (022047) for SEROQUEL XR by ASTRAZENECA

Back to FDA Applications sponsored by ASTRAZENECA

Application Number022047
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
DosageEQ 50MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSEROQUEL XR
Active IngredientQUETIAPINE FUMARATE

Active IngredientCount
List of drugs with Active Ingredient QUETIAPINE FUMARATE3


Back to FDA Applications sponsored by ASTRAZENECA